The acute toxicity study GIZH-290 in mice
https://doi.org/10.37489/2587-7836-2020-4-41-46
Abstract
Acute toxicity testing is a commonly accepted procedure for preclinical testing of the safety of potential drugs. The compound GIZh-290, which is a derivative of 4-phenylpyrrolidone– 2,6 - dimethylanilide (2-oxo-4-phenylpyrrolidine-1-yl) acetic acid and has a nootropic and anticonvulsant effect, was studied. The results obtained after a single oral and intraperitoneal administration to mice allow us to attribute GIZH-290 to the 4th class of toxicity – "lowtoxic substances". The study revealed the neurotoxic effects of GIZH-290, which may be due to the main pharmacological activity of the compound used in sublethal doses.
About the Authors
S. V. AlekseevaRussian Federation
Alekseeva Svetlana V. Senior Research Officer of laboratory of drug toxicolog
Moscow
SPIN code: 8985-3418
A. V. Sorokina
Russian Federation
Sorokina Aleksandra V. – PhD in Biology, Leading researcher of the laboratory of drug toxicology
Moscow
A. V. Volkova
Russian Federation
Volkova Anna V. – Senior Research Officer of laboratory of psychopharmacology
Moscow
V. V. Zabrodina
Russian Federation
Zabrodina Victoria V. – PhD in Biology, Research scientist of the laboratory of drug toxicology
Moscow
SPIN code: 8473-6920
I. A. Miroshkina
Russian Federation
Miroshkina Irina A. – Research scientist of the laboratory of drug toxicology
Moscow
SPIN code: 4697-7938
K. S. Kachalov
Russian Federation
Kachalov Kirill S. – Engineer of the 1st category of the laboratory of drug toxicology FSBI «Zakusov Institute of Pharmacology»; student of the pharmaceutical faculty of the Moscow medical university «Reaviz»
Moscow
SPIN code: 2992-6789
I. V. Alekseev
Russian Federation
Alekseev Ivan V. – Engineer of the 1st category of the Laboratory of Pharmacology of mutagenesis FSBI «Zakusov Institute of Pharmacology»; student of the faculty of pharmacy Moscow Medical University «Reaviz»
Moscow
SPIN code: 9757-6210
A. D. Zaharov
Russian Federation
Zakharov Aleksei D. Junior researcher of the laboratory of drug toxicology
Moscow
SPIN code: 9013-6228
References
1. Zhmurenko LA, Litvinova SA, Mokrov GV et al. Synthesis of 4-phenylpyrrolidone derivatives with anticonvulsant and nootropic activity. Pharmaceutical Chemistry Journal. 2019;53(5):20–27. (In Russ).
2. Kovalev IG, Voronina TA, Litvinova SA et al. Comparison of the anticonvulsant and mnemotropic properties of new derivatives of 4-phenylpyrrolidone, levetiracetam, and piracetam in outbred mice and rats. Experimental and Clinical Pharmacology. 2017;80(6):13–18. (In Russ).
3. Kovalev IG. Poisk soedinenij s protivosudorozhnoj aktivnost'yu sredi novyh proizvodnyh 4-fenilpirrolidona i kumarina i izuchenie ih nejrohimicheskih mekhanizmov dejstviya. Avtoreferat. 2017. (In Russ). https://www.academpharm.ru/images/upload/ru/1454/Dissertaciya__Kovalev_I.G.pdf
4. Makarova MN, Makarov VG, Shekunova EV. Methodological approaches to the assessment of pharmaceutical substances neurotoxicity. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2017;7(2):111–116. (In Russ).
5. Problemy normy v toksikologii / Ed by Prof. IM Trachtenberg. Moscow: Medicine; 1991. (In Russ).]
6. Guidance on Preclinical Evaluation of Medicines. Part 1. Metodicheskie rekomendatsii po izucheniyu obshchetoksicheskogo deistviya lekarstvennykh sredstv. Izuchenie ostroi toksichnosti. Moscow: Grif i K; 2012. (In Russ).
7. GOST 33215-2014 Guidelines for the maintenance and care of laboratory animals. Rules for the equipment of premises and the organization of procedures, Recommendations for the euthanasia of experimental animals. Moscow: 1997. (In Russ).
8. Close B, Banister K, Baumans V et al. Recommendations for euthanasia of experimental animals: Part 1. DGXI of the European Commission. Lab Anim. 1996;30(4):293–316. DOI: 10.1258/002367796780739871
9. Appendix No. 4 " Procedure for euthanasia (killing of an animal)" to the Rules for carrying out work using experimental animals of the Order of the Ministry of Health of the USSR of 12.08.1977. No. 755. (In Russ).
10. Close B, Banister K, Baumans V et al. Recommendations for euthanasia of experimental animals: Part 1. DGXI of the European Commission. Lab Anim. 1997;31(1):1-32. DOI: 10.1258/002367797780600297.
11. Guideline for Experimental (Preclinical) Studying of New Pharmacological Substances. Metodicheskie ukazaniya po izucheniyu obshchetoksicheskogo deistviya farmakologicheskikh veshchestv. Izuchenie «ostroj» toksichnosti. Izuchenie «hronicheskoj» toksichnosti. Moscow: Medicine; 2005. (In Russ).
12. Krasovsky GN, Rakhmanin YuA, Egorova NA. Ekstrapolyaciya toksikologicheskih dannyh s zhivotnyh na cheloveka. Moscow: Medicine; 2019;53(5):20–27. (In Russ).
13. Guide for the Care and Use of Laboratory Animals. National Academies Press (US). Washington (DC). 2011. DOI: 10.17226/12910
14. Pravila doklinicheskoi otsenki bezopasnosti farmakologicheskikh sredstv. RD 64-126-91. Moscow: Rosminzdrav, FK; 1992. (In Russ).
15. Belen'kii M.B. Elementy kolichestvennoi otsenki farmakologicheskogo effekta. Leningrad: Medgiz; 1963. (In Russ).
Review
For citations:
Alekseeva S.V., Sorokina A.V., Volkova A.V., Zabrodina V.V., Miroshkina I.A., Kachalov K.S., Alekseev I.V., Zaharov A.D. The acute toxicity study GIZH-290 in mice. Pharmacokinetics and Pharmacodynamics. 2020;(4):41-47. (In Russ.) https://doi.org/10.37489/2587-7836-2020-4-41-46